Improving HIV care for pregnant teens and young women in Tanzania
Part of Infections, Women’s health & pregnancy clinical trials.
This trial aims to improve HIV prevention and treatment for pregnant adolescents and young women in Tanzania. It includes reviewing medical records, talking to patients and providers, and testing new care approaches.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a female aged 15-24 years
- You are living with HIV
- You are currently pregnant or have been pregnant within the past year
- You started HIV prevention services between 2018 and 2020 (for the record review part)
- You are willing to share your experiences in interviews or group discussions (for the talk-based parts)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help pregnant women with HIV who also have depression, and their partners, reduce the risk of passing HIV to their babies. The program includes support for mental health and HIV care.
This study tests a program to help women at risk for HIV stay healthy while planning or having children. It provides prevention tools and support to reduce the chance of getting HIV.
This study works with clinics in Dar es Salaam, Tanzania to improve pregnancy care for women living in a city, especially as the climate changes. The goal is to help keep mothers and babies healthier.
This study looks at whether young women can get PrEP, a daily pill that prevents HIV, from local pharmacies instead of clinics. It aims to make it easier for adolescent girls and young women to start and continue PrEP in selected areas of Tanzania.
This study is testing a new way to find and treat HIV in pregnant women and new mothers in Malawi. It may help prevent passing HIV from mother to baby.
This study in Zimbabwe tests a program to help pregnant women start and stay on PrEP (medication that prevents HIV). It aims to make PrEP easier to use during pregnancy for women who are at risk of HIV.
Hear when a new HIV Antiretroviral Therapy (ART) Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.